Cat’s Claw Bark (Uncaria tomentosa)

Nomenclature & Taxonomic Classification

• Botanical Binomial: Uncaria tomentosa (Willd. ex Schult.) DC.
• Family: Rubiaceae
• Common Name(s): Cat’s Claw, Uña de Gato, Savéntaro
• Parts Used: Dried inner bark (and root).

Botanical Description, Habitat & Sustainability

• Physical Description: * Growth Habit: Massive, woody, perennial climbing liana reaching up to 30 meters in length.
  • Morphology: Opposite, ovate leaves with fine yellowish hairs on the underside. Characterized by woody, curved, hook-like spines (resembling a cat’s claw) positioned in the leaf axils, which allow the vine to climb high into the forest canopy. Flowers are small, yellowish-white trumpet shapes.
• Habitat & Cultivation: Native to the Amazon rainforest, particularly Peru, Colombia, and Ecuador. Grows in primary and secondary rainforest environments up to 800 meters elevation.
• Sustainability Status: High global commercial demand has threatened wild populations. Sustainable harvesting laws require cutting the vine at least 1 meter above the ground to allow for regeneration, protecting the root system.

Energetics & Traditional Actions

• Western Tissue States: Corrects Irritation/Excitation (profoundly cools systemic inflammatory cascades) and Damp/Relaxation (astringes lax mucosal linings).
• Traditional Vector:
  • Ayurveda: Rasa (Taste): Tikta (Bitter), Kashaya (Astringent) | Virya (Energy): Sheeta (Cooling) | Vipaka (Post-Digestive Effect): Katu (Pungent) | Dosha Modulation: Decreases Kapha and Pitta.
  • Traditional Chinese Medicine: Temperature: Cool to Cold | Taste: Sweet, Slightly Bitter | Organ Meridians Entered: Liver, Pericardium, Large Intestine
• Historical Folk Use: Utilized for centuries by the Asháninka people of Peru for deep-seated immune imbalances, arthritis, tumors, urinary tract infections, and gastrointestinal inflammation.

Phytochemistry & Pharmacological Dynamics

• Primary Phytochemicals: Oxindole alkaloids (pentacyclic oxindole alkaloids [POAs] like pteropodine, isopteropodine, mitraphylline; tetracyclic oxindole alkaloids [TOAs]); quinovic acid glycosides; polyhydroxylated triterpenes; proanthocyanidins.
• Mechanism of Action: > POAs stimulate the proliferation and phagocytic capacity of alveolar macrophages, monocytes, and T-lymphocytes, boosting non-specific immunity. Conversely, quinovic acid glycosides and proanthocyanidins suppress the expression of NF-kB, lowering the synthesis of pro-inflammatory cytokines ($TNF-\alpha$, $IL-1\beta$, $IL-6$) and reducing inducible nitric oxide synthase (iNOS). TOAs, when present, can counteract the immunostimulant benefits of POAs by acting as central nervous system depressants; hence, POA-dominant chemotypes are clinically preferred.

Clinical Applications & Indications

• Primary Indications: Osteoarthritis, rheumatoid arthritis, chronic viral fatigue syndromes, immune deficiency states, and persistent systemic inflammation.
• Secondary Indications: Gastrointestinal dysbiosis, gastritis, leaky gut syndrome, diverticulitis, and post-chemotherapy white blood cell count restoration.
• Modern Clinical Evidence: Randomized, double-blind human clinical trials show that standardized extracts of Uncaria tomentosa significantly reduce knee joint pain during movement and rest in patients with osteoarthritis, without inducing standard NSAID gastrointestinal toxicities.

Preparation, Dosing & Extraction Matrix

• Optimal Menstruum & Extraction Guidelines: Inner bark alkaloids require an acidic aquatic matrix or moderate-to-high alcohol concentrations (50–70% EtOH) for complete extraction. Long, acidic decoctions (adding lemon juice) enhance alkaloid recovery.

Standard Dosage Parameters

Safety Profile, Contraindications & Drug Interactions

• Contraindications: Contraindicated in individuals taking immunosuppressant drugs (due to potential immune-stimulating actions), pre- or post-organ transplant patients, and during pregnancy or lactation.
• Side Effects & Toxicity Thresholds: Extremely safe at conventional doses. High doses can induce transient, mild gastrointestinal disturbances, loose stools, or mild hypotension.
• Pharmaceutical Cross-Interactions: * Enzyme Alterations: May inhibit CYP3A4 pathways, potentially elevating serum levels of drugs like protease inhibitors or specific calcium channel blockers.
  • Additive Pathways: May potentiate the actions of antihypertensive drugs or anticoagulant therapies.

References

1. Keplinger, K., et al. (1999). Uncaria tomentosa (Willd.) DC.—Ethnomedical use and new pharmacological, toxicological and botanical results. Journal of Ethnopharmacology, 64(1), 23-34.
2. Piscoya, J., et al. (2001). Efficacy and safety of freeze-dried cat’s claw in osteoarthritis of the knee: a mechanisms-based, 2-month study. Inflammation Research, 50(9), 442-448.
3. Mur, E., et al. (2002). Randomized double blind trial of an Uncaria tomentosa extract in the treatment of rheumatoid arthritis. The Journal of Rheumatology, 29(4), 720-726.